Genmab A/S - ADR - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
GMAB Nasdaq 8731 https://www.genmab.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Genmab A/S - ADR

Transactions in connection with share buy-back program - Mar 20th, 2023 2:21 pm
Capital Increase in Genmab as a Result of Employee Warrant Exercise - Feb 28th, 2023 7:54 pm
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons - Feb 24th, 2023 8:36 pm
Grant of Restricted Stock Units to Management and Employees and Grant of Warrants to Employees in Genmab - Feb 24th, 2023 8:33 pm
13 High Growth Pharma Stocks that are Profitable - Feb 23rd, 2023 3:50 pm
Notice to Convene the Annual General Meeting of Genmab A/S - Feb 23rd, 2023 11:00 am
Genmab Files Annual Report with the U.S. Securities and Exchange Commission - Feb 22nd, 2023 6:12 pm
Genmab Announces Initiation of Share Buy-Back Program - Feb 22nd, 2023 4:12 pm
Genmab Publishes 2022 Annual Report - Feb 22nd, 2023 4:01 pm
Zacks.com featured highlights Genmab, Hologic, ServiceNow and Splunk - Feb 9th, 2023 10:00 am
Grant of Restricted Stock Units and Warrants to Employees in Genmab - Jan 24th, 2023 7:00 pm
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022 - Jan 24th, 2023 11:27 am
GILD or GMAB: Which Is the Better Value Stock Right Now? - Jan 23rd, 2023 4:40 pm
Artisan Mid Cap Fund Exited Its Position in Genmab A/S (GMAB) For Better Opportunities - Jan 20th, 2023 12:04 pm
Correction to Company Announcement No. 1 of January 3, 2023 - Jan 19th, 2023 4:00 pm
New Strong Buy Stocks for January 11th - Jan 11th, 2023 1:13 pm
3 Biotech Companies to Watch in 2023 - Jan 6th, 2023 11:50 pm
Genmab to Present at the 41st Annual J.P. Morgan Healthcare Conference - Jan 2nd, 2023 12:56 pm
Biotech And Medical Stocks Leading Performers As 2022 Draws To A Close - Dec 23rd, 2022 8:49 pm
Genmab Announces Submission of Japan New Drug Application (JNDA) for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) - Dec 21st, 2022 12:00 pm